FDA NDC Directory · JSON-LD · Markdown

Azacitidine

NDC 31722-365 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215765
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsAZACITIDINE (100 mg/1)
Marketing started20241015
Package count1

External sources

Source: openFDA. Public-domain (CC0).